Cambridge, Massachusetts

Second Massachusetts city to adopt a local entheogenic-plants policy order in 2021, with Harvard and MIT research context kept separate from public legal access.

State status

Partial decriminalization

This page is not a service-center locator, dispensary directory, vendor list, or purchasing guide. State-level frameworks do not change federal controlled-substance status.

What local context does not answer

Local context can explain policy history, state rules, city ordinances, public-health resources, and community support. It cannot determine whether a substance is safe, effective, lawful for a specific person, available through a specific channel, or appropriate for any individual.

Is it legal for me? Legal status depends on substance, activity, jurisdiction, date, and official source.

Can I buy it? Commercial access is separate from legal status and is not addressed here.

Is it safe? Safety depends on medical history, medications, psychiatric risk, dose, and context.

Does it work? Efficacy requires controlled outcome evidence, not location.

Is a source reliable? Source reliability requires independent verification and quality control.

Am I personally eligible? Eligibility depends on program rules, clinician review, and individual facts.

Local policy context

This section summarizes policy context. It is not legal advice or current-law verification.

Cambridge adopted Policy Order POR 2021 #24 on February 3, 2021, after Somerville's January 2021 action. The Cambridge order treated use and possession of controlled substances through a public-health lens and made certain entheogenic-plant enforcement a lowest local priority. Cambridge's Harvard/MIT research context is important, but it should not be framed as legal access or as the source of the municipal policy.

Second Massachusetts local policy Cambridge followed Somerville and became the second Massachusetts municipality to take this local-policy step.

Policy order, not statewide law The action was a city policy order and did not change Massachusetts or federal controlled-substance law.

Research context stays separate Harvard, MIT, and Boston-area medical research provide context only; they do not authorize consumer possession, sales, or use.

No commercial access The local policy does not authorize commercial sale, distribution near schools, impaired driving, or public disturbance.

Legal and policy timeline

This timeline documents policy and legal history. It does not describe current access options.

Feb 3, 2021News
Cambridge adopts entheogenic-plants policy order
Cambridge City Council approved Policy Order POR 2021 #24, following Somerville and making relevant enforcement a lowest local priority.source →
Nov 5, 2024
Massachusetts voters reject statewide Question 4
Question 4's failure means Cambridge remains local-policy context only, without a statewide regulated-access framework.source →

Research institutions

Listed for local research and academic context only. These institutions are not psilocybin providers, endorsers, or access points, and their presence does not mean services, treatment, clinical eligibility, or access are available.

Harvard University
MIT
Harvard Medical School
Massachusetts General Hospital